IGF-1: what is a good level?
Standard reference ranges are age-banded and vary noticeably by lab and sex — a widely used commercial range for the 40s and 50s spans roughly 53 to 298 ng/mL across both sexes combined, with each lab publishing its own narrower band by decade and sex on the report itself.
This is the range used by the metabolic dial in the Longevity Score calculator. It is deliberately tighter than the range printed on a standard lab report — the reasoning is below.
Nothing you type here is sent anywhere, stored, or logged. It never leaves this page.
A result anywhere in the pale band is reported as normal and generates no comment. The brighter band is where risk is lowest. The distance between them is the part a standard report does not tell you.
What IGF-1 actually measures
IGF-1 is produced mainly by the liver in response to growth hormone, and because growth hormone itself pulses unpredictably through the day and is hard to measure directly, IGF-1 — which stays comparatively stable — is used as its practical stand-in on a standard blood draw.
It is scored here as a context marker against your own age band rather than against one universal number, because IGF-1 falls substantially and predictably with age in healthy people — a level that would be low for a 30-year-old can be entirely unremarkable for a 60-year-old.
Why it matters
This is explicitly not a 'higher is always better' marker. Low IGF-1 is linked to reduced muscle mass, slower tissue repair and, in deficiency states, worse metabolic health — but the epidemiological picture at the high end is more complicated: some large cohort studies associate the upper part of the range with higher cancer incidence, which is the opposite direction from most of the markers on this site.
The practical reading most consistent with the evidence is mid-to-upper-normal for your age, not 'maximise it' — which is why this marker is scored with both a floor and a ceiling rather than scored as open-ended.
It sits in the metabolic dial because growth hormone and IGF-1 signalling intersect heavily with insulin sensitivity: the same growth-and-repair axis that builds tissue is tightly linked to how the body partitions fuel.
Why it's on the dashboard
IGF-1 made the panel specifically because it refuses to fit the "more is better" pattern most of this panel follows, and a calculator that pretended otherwise would be giving confidently wrong advice. The evidence for that nuance is unusually direct: in a 22-year study of roughly 100 Ecuadorians with a genetic mutation that keeps IGF-1 very low from birth, Guevara-Aguirre et al. (Science Translational Medicine, 2011) found almost no cancer or diabetes compared with over 1,600 normal-stature relatives — but overall life expectancy was not longer, because deaths from unrelated causes offset the gain. That is the honest lifespan case: pushing IGF-1 low is not a longevity hack, and pushing it high carries its own cancer-incidence signal in other cohorts, which is why this marker is scored with a band rather than a direction. The healthspan case is more straightforward: IGF-1 drives the anabolic signalling behind muscle maintenance and tissue repair, so levels toward the low end of normal track with reduced muscle mass and slower recovery, independent of the cancer question above. See the Metabolic dial for the broader context.
Why this range is stricter than your lab's
A standard lab report answers 'is this typical for my age and sex', which can mean 'typical for an unhealthy population at that age' — commercial reference ranges are built from whoever happened to get tested, which skews toward people with existing symptoms or risk factors.
The optimised band used here is a mid-to-upper-normal target for working-age adults rather than either extreme of the published range, reflecting where the balance of evidence on muscle, metabolic health and cancer risk currently sits — not a push toward the ceiling.
This distinction applies across the whole panel, not just this marker — see optimal versus standard lab ranges for the general case.
What moves IGF-1
Educational information, not a treatment plan. Discuss changes to medication or supplementation with a clinician who knows your history.
How fast it responds
Months. IGF-1 reflects sustained growth-hormone signalling and nutritional status rather than anything that moves week to week; a sensible retest interval is six to twelve months unless a specific clinical concern is being tracked. See response times across all markers for how this compares.
What can distort the result
- Must be interpreted against an age- and sex-matched reference band — a number with no age context attached cannot be read at all.
- Acute illness, recent surgery and poor nutritional status all suppress IGF-1 independent of baseline growth-hormone function.
- Because the epidemiology at the high end is genuinely mixed, an elevated result is a prompt for clinical context, not an automatic concern — but a markedly high result, especially with symptoms, should be discussed with a doctor rather than dismissed.
- This is a context marker, not a target to chase with supplements — several substances marketed to 'boost IGF-1' have weak evidence and some (exogenous growth hormone or its secretagogues) carry real risk when used outside a diagnosed deficiency.
Frequently asked questions
What is a good IGF-1 level?
The longevity-optimised target used in this calculator is Scored against your own age band, not one fixed number. Representative midlife band: 120–220 ng/mL optimal, 90–280 ng/mL good, 60–310 ng/mL borderline.. Standard reference ranges are age-banded and vary noticeably by lab and sex — a widely used commercial range for the 40s and 50s spans roughly 53 to 298 ng/mL across both sexes combined, with each lab publishing its own narrower band by decade and sex on the report itself.
Why is this target stricter than the range on my lab report?
A standard lab report answers 'is this typical for my age and sex', which can mean 'typical for an unhealthy population at that age' — commercial reference ranges are built from whoever happened to get tested, which skews toward people with existing symptoms or risk factors.
How fast does IGF-1 respond to change?
Months. IGF-1 reflects sustained growth-hormone signalling and nutritional status rather than anything that moves week to week; a sensible retest interval is six to twelve months unless a specific clinical concern is being tracked.
Related markers
IGF-1 feeds the metabolic dial, and read it alongside Fasting Insulin · HbA1c.